
Fall 2020 Kickstarter Awards Competition Results
MEDEA Study & RHEA Study Awarded Kickstarter Funding Awards
Learn more
Interested in Becoming a National VTE Research Network
Learn more
Fostering International VTE Research Collaboration
INVENT-VTE seeks to improve the care of patients affected by venous thromboembolism (VTE) around the world through the design, development, conduct and promotion of high-quality clinical research into the causes, prevention, diagnosis and optimal management of VTE.
Endorsed Studies
TILE
Tinzaparin Lead-In to Prevent the Post-Thrombotic Syndrome
Sponsor:
Sunnybrook Health Sciences Centre
Toronto, Canada
Current Participant(s):
Canada, France,Status:
- Seeking sites and collaborators
Lead Network:
CanVECTORPLATO-VTE
Platelet mRNA profiling to detect occult cancer in unprovoked venous thromboembolism
Sponsor:
Academic Medical Center
Amsterdam, the Netherlands
Current Participant(s):
Belgium, Canada, Germany, Italy, Spain, The Netherlands, USA,Status:
- Recruitment Completed
- Analyzing Results
Lead Network:
DTNRIVASVT-100
Treatment of portal, mesenteric, and splenic vein thrombosis with rivaroxaban. A pilot, prospective cohort study
Sponsor:
Università degli Studi dell'Insubria
Varese, Italy
Current Participant(s):
Canada, France, Germany, Italy,Status:
- Recruited started 2015
Lead Network:
TRIPVERDICT
Venous thromboembolism in renally impaired patients and direct oral anticoagulants
Sponsor:
Centre Hospitalier Universitaire de Saint Etienne
Saint Etienne, France
Current Participant(s):
Canada, France, Serbia, Spain, Switzerland,Status:
- Seeking sites and collaborators
Lead Network:
INNOVTERENOVE
REduced dose versus full-dose of direct oral anticoagulant after uNprOvoked Venous thromboEmbolism. The RENOVE open-label, randomized, controlled trial
Sponsor:
Brest University Hospital
Brest, France
Current Participant(s):
France,Status:
- Seeking sites and collaborators
Lead Network:
INNOVTESAVER
Statins for Venous Event Reduction in Patients with Venous Thromboembolism
Sponsor:
Ottawa Hospital Research Institute
Current Participant(s):
Canada,Status:
- Pilot trial recruitment completed in Canada and Norway
- Secured Funding to Begin Full Trial
Lead Network:
CanVECTORTHEIA
Advanced diagnostic management of suspected recurrent ipsilateral deep vein thrombosis of the leg with magnetic resonance direct thrombus imaging
Sponsor:
Leiden University Medical Center
Current Participant(s):
Canada, Norway, Sweden, The Netherlands,Status:
Lead Network:
DTNHIGHLOW
Low-molecular-weight heparin to prevent recurrent VTE in pregnancy: a randomized controlled trial of two doses
Current Participant(s):
Belgium, Canada, France, Ireland, Norway, The Netherlands, USA,Status:
- Recruitment Completed
- Analyzing Results
Lead Network:
DTNALIFE2
Anticoagulants for living fetuses in women with recurrent miscarriage and inherited thrombophilia
Current Participant(s):
Belgium, Canada, The Netherlands, USA,Status:
- Recruiting
- Seeking sites and collaborators
Lead Network:
DTNPEITHO-III
A reduced dose of thrombolytic treatment for patients with intermediate high-risk acute pulmonary embolism
Sponsor:
Hopital Européen Georges Pompidou, Assistance Publique Hopitaux de Paris, Université Paris Descartes
Current Participant(s):
Belgium, Canada, France, Germany, Italy, Poland, Romania, Spain, The Netherlands,Status:
- Seeking sites and collaborators
Lead Network:
INNOVTEPilot PARTUM
Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity
Sponsor:
University of Calgary
Current Participant(s):
Canada, The Netherlands, USA,Status:
Planning to begin recruitment in January 2020
Lead Network:
CanVECTORADJUST-DVT
Age-adjusted d-dimer cutoff levels to rule out deep vein thrombosis
Sponsor:
University Hospital
Geneva, Switzerland
Current Participant(s):
Canada, Switzerland,Status:
- Recruiting
- Seeking sites & collaborators
Lead Network:
INNOVTEREDUCE
Management of recurrent venous thromboembolism during anticoagulant treatment in cancer patients - a prospective cohort study
Sponsor:
Amsterdam University Medical Center
Amsterdam, the Netherlands
Current Participant(s):
Italy, The Netherlands,Lead Network:
DTNRhea
Optimizing diagnosis of splanchnic vein thrombosis with MR direct thrombus imaging
Sponsor:
- The Netherlands: Dutch Thrombosis Network (Leiden University Medical Center, Leiden; Erasmus Medisch Centrum, Rotterdam)
- Italy: Thrombosis Research Italian Partnership (Varese University Hospital, Varese)
Current Participant(s):
Italy, The Netherlands,Lead Network:
DTNCOBRRA
Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism
Sponsor:
OHRI (Ottawa Hospital Research Institute)
Current Participant(s):
Australia & New Zealand, Canada,Lead Network:
CanVECTORREMAP-ATTACC
Antithrombotic Therapy to Ameliorate Complications of COVID-19
Sponsor:
University of Manitoba
Collaborator: University Health Network, Toronto
Current Participant(s):
Canada,Status:
Recuiting
Lead Network:
CanVECTORRAPID COVID COAG
Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic
Sponsor:
St. Michael's Hospital, Toronto
Collaborator: University of Vermont Medical Center
Current Participant(s):
Canada, The Netherlands, USA,Status:
Recruiting
Lead Network:
CanVECTORSAFE-SSPE
Clinical Surveillance vs. Anticoagulation For low-risk patiEnts with isolated SubSegmental Pulmonary Embolism: a multicenter randomized placebo-controlled non-inferiority trial
Sponsor:
Inselspital, Bern University Hospital, University of Bern
Current Participant(s):
Canada, Switzerland, The Netherlands,Status:
Recruiting
Lead Network:
DTNMEDEA
Heavy MEnstrual bleeding in premenopausal women treated with DirEct oral Anticoagulants
Sponsor:
Amsterdam University Medical Center
Current Participant(s):
Ireland, The Netherlands,Status:
Recruiting
Lead Network:
DTNDeterminants and Impact of the Post- Venous Thromboembolism (VTE) Syndromes
Determinants and Impact of the Post- Venous Thromboembolism (VTE) Syndromes
Sponsor:
Leiden University Medical Center, Leiden, The Netherlands.
Current Participant(s):
Canada, Ireland, The Netherlands,Lead Network:
DTNLEaD
Safely Ruling out Deep Vein Thrombosis in Pregnancy with the LEFt Clinical Decision Rule and D-dimer
Sponsor:
- Ottawa Hospital Research Institute
Current Participant(s):
Canada, Switzerland, The Netherlands,Status:
- Recruiting
- Seeking new sites and collaborators
Lead Network:
CanVECTORReal-World Use of DOACs in Children: An International Registry
Real-World Use of DOACs in Children: An International Registry
Sponsor:
- Children’s Hospital of Philadelphia
- University of Amsterdam
Current Participant(s):
The Netherlands, USA,Lead Network:
VENUSSubscribe